Atlas Trials

Role of UC-MSC and CM to Inhibit Vision Loss in Retinitis Pigmentosa Phase I/II

Clinical trial NCT05909488 · NOT_YET_RECRUITING

Trial details

NCT number
NCT05909488
Sponsor
PT. Prodia Stem Cell Indonesia
Status
NOT_YET_RECRUITING
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Retinitis Pigmentosa
Start date
2026-05-01
Primary completion
2027-07-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.